RBC Capital Reiterates Outperform on Boston Scientific, Maintains $85 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Boston Scientific (NYSE:BSX) and maintained a price target of $85.
July 25, 2024 | 3:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its Outperform rating on Boston Scientific and maintained a price target of $85, indicating continued confidence in the company's performance.
The reiteration of an Outperform rating and a maintained price target of $85 by RBC Capital suggests strong confidence in Boston Scientific's future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100